安全性研究支持免疫治疗溶瘤麻疹疫苗的临床开发。

{"title":"安全性研究支持免疫治疗溶瘤麻疹疫苗的临床开发。","authors":"Christine E Engeland","doi":"10.1016/j.omtm.2022.09.003","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517056,"journal":{"name":"Molecular Therapy. Methods & Clinical Development","volume":" ","pages":"90-92"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/77/37/main.PMC9515431.pdf","citationCount":"1","resultStr":"{\"title\":\"Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine.\",\"authors\":\"Christine E Engeland\",\"doi\":\"10.1016/j.omtm.2022.09.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517056,\"journal\":{\"name\":\"Molecular Therapy. Methods & Clinical Development\",\"volume\":\" \",\"pages\":\"90-92\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/77/37/main.PMC9515431.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Therapy. Methods & Clinical Development\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.omtm.2022.09.003\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/12/8 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Therapy. Methods & Clinical Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.omtm.2022.09.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/12/8 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}